ISO 16037:2002/Amd 1:2011

Overview

ISO 16037:2002/Amd 1:2011 is an important international standard published by the International Organization for Standardization (ISO) that specifies the measurement of physical properties of rubber condoms intended for clinical trials. This amendment to the original ISO 16037:2002 standard provides updated procedures and guidelines to ensure consistent quality and reliability of condoms used in clinical research settings.

The standard is developed by ISO Technical Committee ISO/TC 157, which specializes in non-systemic contraceptives and barrier prophylactics against sexually transmitted infections (STIs). Its main goal is to provide precise measurement methods that support the evaluation of condom performance, safety, and compliance with physical property requirements.

Key Topics

• Measurement Procedures: The amendment revises specific measurement techniques, including the use of micrometers with a pressure-controlled probe to accurately measure condom thickness and diameter. For example, micrometers must apply a pressure of (22 ± 5) kPa and use probe diameters of (5 ± 2) mm, as described in ISO 4074.

• Sample Size Requirements: The amendment increases the minimum number of condoms tested per batch from 315 to 500, enhancing the statistical reliability of test results. It also recommends testing at least 2,000 samples to obtain more precise estimates of conformity and defect rates.

• Physical Property Testing: Detailed instructions are given on measuring condom mass and thickness using methods consistent with ISO 4074. Obsolete methods such as the "weighing method" terminology have been updated for clarity.

• Quality Assurance and Monitoring: Emphasis is placed on ongoing monitoring of condom physical properties throughout clinical trials to detect any changes that could affect performance or safety. This includes tracking manufacturing dates and other factors relevant to product quality.

• Data Analysis and Reporting: The standard advises summarizing results with histograms or tree diagrams to visualize quality distributions within lots, facilitating robust quality control decisions.

Applications

ISO 16037:2002/Amd 1:2011 is primarily used by:

• Manufacturers of Clinical Trial Condoms: To ensure that their products meet stringent physical property criteria before release.

• Clinical Trial Sponsors and Researchers: To verify the quality and consistency of condoms used in efficacy and safety studies, supporting valid and reliable clinical outcomes.

• Quality Control Laboratories: To implement standardized measurement techniques and report accurate, reproducible data on condom physical characteristics.

• Regulatory Authorities: To enforce compliance with internationally recognized condom standards, thereby protecting public health during clinical investigations.

By adhering to this standard, stakeholders can enhance confidence in condom performance, contributing to successful clinical trial execution and improved STI prevention strategies.

Related Standards

• ISO 4074: This standard defines the requirements for natural rubber latex condoms for male use, including testing methods for physical properties such as thickness, length, and tensile strength. ISO 16037 references ISO 4074 extensively for measurement procedures.

• ISO 13485: Quality management systems for medical devices, which may complement condom manufacturing processes aimed at clinical use.

• ISO/TR 16630: A technical report providing guidelines related to barrier contraceptives and their evaluation.

• ISO 10993 Series: Biological evaluation of medical devices, relevant for assessing biocompatibility aspects of rubber condoms used in trials.

Conclusion

The ISO 16037:2002/Amd 1:2011 amendment plays a critical role in standardizing the measurement of physical properties of rubber condoms used in clinical trials. It supports enhanced quality assurance, helps maintain regulatory compliance, and ensures the reliability of condoms used as barrier prophylactics during clinical research. For manufacturers, researchers, and regulators worldwide, this standard offers practical guidance to achieve consistent, reproducible, and validated test results-ultimately aiding the development and deployment of safe and effective contraceptive products.